Obi Greenman

Vorstandsvorsitzender bei CERUS CORPORATION

Vermögen: 5 Mio $ am 30.04.2024

57 Jahre

Health Technology

Consumer Services

Aktive Positionen von Obi Greenman

Unternehmen	Position	Beginn	Ende
CERUS CORPORATION	Direktor/Vorstandsmitglied	21.04.2011	-
	Vorstandsvorsitzender	21.04.2011	-
	Präsident	21.04.2011	-
	Corporate Officer/Principal	01.01.1999	01.08.2008
	Vertrieb & Marketing	01.08.2008	21.04.2011

Unternehmen	Position	Beginn	Ende
CHINOOK THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	01.06.2010	11.08.2023
CHINOOK THERAPEUTICS, INC.	Independent Dir/Board Member	01.06.2010	11.08.2023
BAXTER INTERNATIONAL INC.	Corporate Officer/Principal	01.01.1995	01.01.1995
CHINOOK THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	23.06.2011	-
CHINOOK THERAPEUTICS, INC.	Independent Dir/Board Member	01.06.2010	-

Stanford University

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Director/Board Member	3
Corporate Officer/Principal	2
Independent Dir/Board Member	2

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
CERUS CORPORATION	Health Technology
BAXTER INTERNATIONAL INC.	Health Technology

Private Unternehmen	2
Aduro BioTech, Inc. Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.	Health Technology
Chinook Therapeutics, Inc. Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.	Health Technology

Private Unternehmen

Health Technology